Published August 4, 2021
| Version 1
Dataset
Open
Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'
Description
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Notes
funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project "COVIM")
Files
Files
(828.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:b8cbf0fb11e424ff86ebf619e2aef58f
|
828.4 kB | Download |